biogen developed the drug , called aduncanumab , wants to recruit at least 1,000 patients for tests by the end of the year .
it is not yet known if this will include any from the uk .
a new alzheimer 's drug reverses the damage the disease causes in patients ' brains could ` change the landscape ' of future treatment .